You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 14 Next »

The following diagram for a crossover trial does not use the crossing slanted lines sometimes used to represent crossover trials, because the order of the blocks is sufficient to represent the design of the trial. Slanted lines are used only to represent the branch point at randomization, when a subject is assigned to a sequence of study product exposures. As in most crossover trials, the arms are distinguished by the order of study product exposures, with the same study product exposure present in each arm. Note that even though all 3 arms of this trial end with the same block (i.e., the block for the follow-up element), the diagram does not show the arms converging into one block. Also note that the same block (the "rest" element) occurs twice within each arm. Elements are conceived of as "reusable" and can appear in more than 1 arm, in more than 1 epoch, and more than once in an arm.

Example Study 2, Crossover Trial Study Schema
  Example Trial 2, Study Schema Copy

The next diagram for this crossover trial shows the prospective view of the trial; it identifies the epoch and arms of the trial, and gives each a name. As for most crossover studies, the objectives of the trial will be addressed by comparisons between the arms and by within-subject comparisons between study product exposures. Because the design depends on differentiating the periods during which the subject receives the 3 different study product exposures, there are 3 different study product exposure epochs. The fact that the rest periods are identified as separate epochs suggests that these also play an important part in the design of the trial; they are probably designed to allow subjects to return to “baseline,” with data collected to show that this occurred. Note that epochs are not considered reusable; each epoch has a different name, even though all the study product exposure epochs are similar and both the rest epochs are similar. As with the first example trial, there is a one-to-one relationship between the epochs of the trial and the elements in each arm.

Error rendering macro 'excerpt-include'

No link could be created for 'Example Trial 2, Crossover Trial Prospective View'.

 
Unable to render {include} The included page could not be found.

The next diagram shows the retrospective view of the trial.

Error rendering macro 'excerpt-include'

No link could be created for 'Example Trial 2, Crossover Trial Retrospective View'.

 
Unable to render {include} The included page could not be found.

The last diagram for this trial shows the trial from the viewpoint of blinded participants. As in the simple parallel trial in Example Trial 1, blinded participants see only 1 sequence of elements; during the product exposure epochs they do not know which of the product exposure elements a subject is in.

Example Study 2, Crossover Study Blinded View
 
Trial 2 Blinded View Copy

The following table illustrates the trial design matrix for this crossover example trial. It corresponds closely to the preceding retrospective diagram.

Trial Design Matrix


ScreenFirst Study Product ExposureFirst RestSecond Study Product ExposureSecond RestThird Study Product ExposureFollow-up
U-A-BScreenUsual Tobacco ProductRestTobacco Product ARestTobacco Product BFollow-up
A-U-BScreenTobacco Product ARestUsual Tobacco ProductRestTobacco Product BFollow-up
B-A-UScreenTobacco Product BRestTobacco Product ARestUsual Tobacco ProductFollow-up

It is straightforward to produce the TA dataset for this crossover trial from the diagram showing arms and epochs, or from the trial design matrix.

ta.xpt

ta.xpt

RowSTUDYIDDOMAINARMCDARMTAETORDETCDELEMENTTABRANCHTATRANSEPOCH
1EX2TAU-A-BUTP-TPA-TPB1SCRNScreenRandomized to UTP -TPA-TPB
SCREENING
2EX2TAU-A-BUTP-TPA-TPB2UTPUsual

STUDY PRODUCT EXPOSURE 1
3EX2TAU-A-BUTP-TPA-TPB3RESTRest

WASHOUT 1
4EX2TAU-A-BUTP-TPA-TPB4TPAProd A

STUDY PRODUCT EXPOSURE 2
5EX2TAU-A-BUTP-TPA-TPB5RESTRest

WASHOUT 2
6EX2TAU-A-BUTP-TPA-TPB6TPBProd B

STUDY PRODUCT EXPOSURE 3
7EX2TAU-A-BUTP-TPA-TPB7FUFollow-up

FOLLOW-UP
8EX2TAA-U-BTPA-UTP-TPB1SCRNScreenRandomized to TPA- UTP- TPB
SCREENING
9EX2TAA-U-BTPA-UTP-TPB2TBAProd A

STUDY PRODUCT EXPOSURE 1
10EX2TAA-U-BTPA-UTP-TPB3RESTRest

WASHOUT 1
1EX2TAA-U-BTPA-UTP-TPB4UTPUsual

STUDY PRODUCT EXPOSURE 2
12EX2TAA-U-BTPA-UTP-TPB5RESTRest

WASHOUT 2
13EX2TAA-B-UTPA-UTP-TPB6TPBProd B

STUDY PRODUCT EXPOSURE 3
14EX2TAA-B-UTPA-UTP-TPB7FUFollow-up

FOLLOW-UP
15EX2TAA-B-UTPA-TPB-Usual1SCRNScreenRandomized to TBA - TPB – Usual
SCREENING
16EX2TAA-B-UTPA-TPB-Usual2TPAProd A

STUDY PRODUCT EXPOSURE 1
17EX2TAA-B-UTPA-TPB-Usual3RESTRest

WASHOUT 1
18EX2TAA-B-UTPA-TPB-Usual4TPBProd B

STUDY PRODUCT EXPOSURE 2
19EX2TAA-B-UTPA-TPB-Usual5RESTRest

WASHOUT 2
20EX2TAA-B-UTPA-TPB-Usual6UTPUsual

STUDY PRODUCT EXPOSURE 3
21EX2TAA-B-UTPA-TPB-Usual7FUFollow-up

FOLLOW-UP
$warningHtml
  • No labels